Considerations for Successful Scale-Up To Tox Batches And Phase-Api (Bulk Drugsubstance): LOJMS- Lupine Publishers

Considerations for Successful Scale-Up To Tox Batches And Phase-Api (Bulk Drugsubstance) by
Krishna Sarma Pathy in LOJ Medical Sciences in Lupine Publishers

Practical Considerations in Pharmaceutical Production Scale-Up- This paper is meant to provide a high-level overview of the steps required to prepare the bulk drug substance API. From first-in-human and through each of the clinical trial stages and into commercialization, scale-up of formulation design is a natural part of pharmaceutical development. At each stage of process development, the batch size increases, from laboratory-scale batches that may be quite small to support preclinical and early clinical stages, to pilot batches that are used in process development, and finally to the production-scale batches needed to support commercialization.

https://www.lupinepublishers.com/medical-science-journal/abstracts/considerations-for-successful-scale-up-to-tox-batches-and-phase-api.ID.000112.php 
https://www.lupinepublishers.com/medical-science-journal/fulltext/considerations-for-successful-scale-up-to-tox-batches-and-phase-api.ID.000112.php
https://www.lupinepublishers.com/downloadPdf.php?folder=medical-science-journal&file=LOJMS.MS.ID.000112

For more Lupine publishers open access journals click the below link
www.lupinepublishers.com

For more medical sciences journals click the below link
www.lupinepublishers.com/medical-science-journal/